Drug recall
Ampicillin for Injection, USP, ampicillin sodium equivalent to 250 mg ampicillin RX only; a lyophilized powder…
FDA recall event 45422 · Class III · Abraxis Pharmaceutical Products
Key facts
| Event ID | 45422 |
|---|---|
| Recall numbers | D-027-2008 |
| Recalling firm | Abraxis Pharmaceutical Products |
| Product type | Drugs |
| Products | Ampicillin for Injection, USP, ampicillin sodium equivalent to 250 mg ampicillin RX only; a lyophilized powder for injection antibiotic in a single dose vial, 10 vials per shelf carton; Manufactured… |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Mislabeled; incorrect dilution instructions printed on outer carton. |
| Initiation date | Oct 18, 2007 |
| Termination date | Oct 16, 2008 |
| City | Rosemont |
| State | IL |
| Country | United States |
| FEI number | 3005734179 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports